| Eric E. Schadt | |
|---|---|
| Photo placeholder | |
| Affiliations | Icahn School of Medicine at Mount Sinai |
| Country | USA |
| H-index | 165 |
| ORCID | 0000-0002-8442-4935 |
| Research Focus | Alzheimer's Disease, Systems biology, Network medicine |
| Mechanisms | Genomics, Systems biology, Network medicine, Computational biology |
Eric E. Schadt is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Eric E. Schadt is the Dean for Precision Medicine and Professor of Genetics and Genomic Sciences at the Icahn School of Medicine at Mount Sinai. He holds the Mount Sinai Professorship in Predictive Health and Computational Biology and is the founder and CEO of Sema4, a Mount Sinai venture focused on precision medicine. Dr. Schadt is a pioneer in network medicine and systems biology approaches to understanding complex human diseases, including Alzheimer's Disease, diabetes, and obesity.
Dr. Schadt received his BA in applied mathematics and computer science from California Polytechnic State University, his MA in pure mathematics from the University of California, Davis, and his PhD in bio-mathematics with candidacy in molecular biology and mathematics from UCLA.
Before joining Mount Sinai in 2011, Dr. Schadt held key leadership positions including Chief Scientific Officer at Pacific Biosciences, Executive Scientific Director of Genetics at Rosetta Inpharmatics (Merck), and Senior Research Scientist at Roche Bioscience. His career has been dedicated to integrating computational approaches with molecular biology to advance our understanding of human disease.
Dr. Schadt is renowned for advocating a network-oriented perspective in molecular biology to complement traditional reductionist single-gene approaches. His work constructs molecular networks that define disease states and connect molecular biology to physiology, enabling more accurate modeling of complex biological systems. This approach has been particularly influential in understanding the multifactorial nature of Alzheimer's Disease and other complex disorders.
As Dean for Precision Medicine at Mount Sinai, Dr. Schadt leads initiatives to integrate large-scale genomic data with clinical information to develop personalized approaches to disease prevention and treatment. His work on Sema4 focuses on transforming healthcare through predictive modeling and precision diagnostics.
Dr. Schadt's contributions to Alzheimer's research include applying systems biology approaches to identify gene networks associated with AD pathogenesis. His work has helped identify novel therapeutic targets and biomarkers through integration of multi-omics data from AD patients.
Recent publications by [Eric E. Schadt--TEMP--/researchers)--FIX-- focus on network biology, systems genetics, and computational approaches to neurodegenerative disease.
The study of Eric E. Schadt has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Page auto-generated from NeuroWiki researcher database. Last updated: 2026-03-01.
Eric E. Schadt is the Founder of Sage Bionetworks, a nonprofit that enables open-source collaboration in biomedical research, and was previously the Icahn Institute for Genomics and Multiscale Biology at Mount Sinai. He is a pioneering figure in computational biology and systems medicine, applying machine learning and network biology approaches to understand complex diseases.
Dr. Schadt's work has transformed how we approach complex diseases by treating them as perturbed networks rather than single gene disorders. His network-based methods have identified novel therapeutic targets and biomarkers for Alzheimer's disease and ALS.
The Sage Bionetworks platform he founded has become a cornerstone of open science in biomedical research, enabling unprecedented collaboration and data sharing across institutions.
Eric E. Schadt is the Founder of Sage Bionetworks, a nonprofit that enables open-source collaboration in biomedical research, and was previously the Icahn Institute for Genomics and Multiscale Biology at Mount Sinai. He is a pioneering figure in computational biology and systems medicine, applying machine learning and network biology approaches to understand complex diseases.
Dr. Schadt's work has transformed how we approach complex diseases by treating them as perturbed networks rather than single gene disorders. His network-based methods have identified novel therapeutic targets and biomarkers for Alzheimer's disease and ALS.
The Sage Bionetworks platform he founded has become a cornerstone of open science in biomedical research, enabling unprecedented collaboration and data sharing across institutions.
Eric E. Schadt is the Founder of Sage Bionetworks, a nonprofit that enables open-source collaboration in biomedical research, and was previously the Icahn Institute for Genomics and Multiscale Biology at Mount Sinai. He is a pioneering figure in computational biology and systems medicine, applying machine learning and network biology approaches to understand complex diseases.
Dr. Schadt's work has transformed how we approach complex diseases by treating them as perturbed networks rather than single gene disorders. His network-based methods have identified novel therapeutic targets and biomarkers for Alzheimer's disease and ALS.
The Sage Bionetworks platform he founded has become a cornerstone of open science in biomedical research, enabling unprecedented collaboration and data sharing across institutions.
Eric E. Schadt is the Founder of Sage Bionetworks, a nonprofit that enables open-source collaboration in biomedical research, and was previously the Icahn Institute for Genomics and Multiscale Biology at Mount Sinai. He is a pioneering figure in computational biology and systems medicine, applying machine learning and network biology approaches to understand complex diseases.
Dr. Schadt's work has transformed how we approach complex diseases by treating them as perturbed networks rather than single gene disorders. His network-based methods have identified novel therapeutic targets and biomarkers for Alzheimer's disease and ALS.
The Sage Bionetworks platform he founded has become a cornerstone of open science in biomedical research, enabling unprecedented collaboration and data sharing across institutions.
Eric E. Schadt is the Founder of Sage Bionetworks, a nonprofit that enables open-source collaboration in biomedical research, and was previously the Icahn Institute for Genomics and Multiscale Biology at Mount Sinai. He is a pioneering figure in computational biology and systems medicine, applying machine learning and network biology approaches to understand complex diseases.
Dr. Schadt's work has transformed how we approach complex diseases by treating them as perturbed networks rather than single gene disorders. His network-based methods have identified novel therapeutic targets and biomarkers for Alzheimer's disease and ALS.
The Sage Bionetworks platform he founded has become a cornerstone of open science in biomedical research, enabling unprecedented collaboration and data sharing across institutions.